Elanco Animal Health Inc at Morgan Stanley Healthcare Conference Transcript
Thanks very much for joining us for the Elanco session. My name is Dave Risinger. I cover major and specialty pharmaceuticals at Morgan Stanley. I need to refer you to the disclaimers at www.morganstanley.com/researchdisclosures.
Just to give you a quick intro on Jeff Simmons who is the company's Chairman and CEO. As head of Elanco Animal Health for the past decade, Jeff has directed the company's transformation from primarily a U.S. feed additive company to a premier global player with a balanced and diversified business. And obviously, the transaction that the company has announced with Bayer further diversifies them, dramatically boosts their presence both in Companion Animals and also geographically in emerging markets. And so we're very much pleased to have Jeff with us today.
Jeff, I'd thought I'd turn it over to you to kick off with some comments, and then we'll take it
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
